Brodie, 2016, Pharmacological treatment of drug-resistant epilepsy in adults: a practical guide, Curr Neurol Neurosci Rep, 16, 82, 10.1007/s11910-016-0678-x
Jette, 2016, Refractory epilepsy is a life-threatening disease: lest we forget, Neurology, 86, 1932, 10.1212/WNL.0000000000002707
Loscher, 2013, New avenues for antiepileptic drug discovery and development, Nat Rev Drug Discov, 12, 757, 10.1038/nrd4126
Engel, 2016, What we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture, Neurology, 87, 2483, 10.1212/WNL.0000000000003407
Patsalos, 2013, Drug interactions with the newer antiepileptic drugs (AEDs) part-1: pharmacokinetic and pharmacodynamic interactions between AEDs, Clin Pharmacokinet, 52, 927, 10.1007/s40262-013-0087-0
Berg, 2010, Comorbidities in epilepsies: overview, 1321
Benbadis, 2010, Non-pharmacological treatments for epilepsies: overview, 1621
Goodfellow, 2016, Estimation of brain network ictogenicity predicts outcome from epilepsy surgery, Sci Rep, 6, 29215, 10.1038/srep29215
Gschwind, 2016, Modern management of seizures and epilepsy, Swiss Med Wkly, 146, w14310
Jobst, 2015, Resective epilepsy surgery for drug resistant focal epilepsy: a review, JAMA, 313, 285, 10.1001/jama.2014.17426
Bejarano, 2015, Autophagy and amino acid metabolism in the brain: implications for epilepsy, Amino Acids, 47, 2113, 10.1007/s00726-014-1822-z
Szyndler, 2008, Changes in the concentration of amino acids in the hippocampus of pentylenetetrazole kindled rats, Neurosci Lett, 439, 245, 10.1016/j.neulet.2008.05.002
Van Gelder, 1972, Amino acids content of epileptogenic human brain: focal versus surrounding regions, Brain Res, 40, 385, 10.1016/0006-8993(72)90141-2
Clanton, 2017, Control of seizures by ketogenic diet-induced modulation of metabolic pathways, Amino Acids, 49, 1, 10.1007/s00726-016-2336-7
Ebrahimi, 2015, Evaluation of charged amino acids on uncontrolled seizures, Neurol Res Int, 2015, 124507, 10.1155/2015/124507
El ldrissi, 1999, Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism, J Neurosci, 19, 9459, 10.1523/JNEUROSCI.19-21-09459.1999
Wu, 2005, Mode of action of taurine as a neuroprotector, Brain Res, 1038, 123, 10.1016/j.brainres.2005.01.058
Jia, 2008, Taurine is a potent activator of extra synaptic GABA (A) receptors in the thalamus, J Neurosci, 28, 106, 10.1523/JNEUROSCI.3996-07.2008
Malminen, 1986, Modulation of the GABA-benzodiazepine receptor complex by taurine in rat brain membranes, Neurochem Res, 11, 85, 10.1007/BF00965168
L’Amoreaux, 2010, Pharmacological characterization of GABAA receptors in taurine-fed mice, J Biomed Sci, 17, 14, 10.1186/1423-0127-17-S1-S14
Levinskaya, 2006, Increased GAD-positive neurons in the cortex of taurine fed mice, Adv Exp Med Biol, 583, 411, 10.1007/978-0-387-33504-9_46
Joseph, 1976, Taurine and cobalt induced epilepsy in the rat: a biochemical and electrocorticographic study, J Neurochem, 27, 1495, 10.1111/j.1471-4159.1976.tb02635.x
Lasley, 1991, Roles of neurotransmitter amino acids in seizure severity and experience in the genetically epilepsy prone rats, Brain Res, 560, 63, 10.1016/0006-8993(91)91215-M
Ghandforoush sattari, 2010, Pharmacokinetics of oral taurine in healthy volunteers, J Amino Acids, 2010, 346237, 10.4061/2010/346237
Loscher, 2016, The search for new screening models of pharmacoresistant epilepsy: is induction of acute seizure in epileptic rodents a suitable approach?, Neurochem Res., 42, 1926, 10.1007/s11064-016-2025-7
Singh, 2014, Characterization of a lamotrigine resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanism, Basic Clin Pharmacol Toxicol, 115, 373, 10.1111/bcpt.12238
Srivastava, 2012, Carbamazepine but not valproate, displays pharmacoresistance in lamotrigine resistant amygdale kindled rats, Epilepsy Res, 104, 26, 10.1016/j.eplepsyres.2012.10.003
Srivastava, 2013, Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy, Epilepsia, 54, 1186, 10.1111/epi.12234
Mishra, 2013, Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy, Neurochem Res, 38, 2503, 10.1007/s11064-013-1163-4
Pahwa, 2016, Ameliorative effect of Asparagus racemosus root extract against pentylenetetrazole induced kindling and associated depression and memory deficit, Epilepsy Behav, 57, 196, 10.1016/j.yebeh.2016.01.025
Singh, 2013, Effect of saponin fraction from Ficus religiosa on memory deficit, behavioural and biochemical impairments in pentylenetetrazole kindled mice, Epilepsy Behav, 27, 206, 10.1016/j.yebeh.2012.11.004
Brodie, 2010, Pharmacological properties of antiepileptic drugs and their significance in clinical practice, 1425
Löscher, 2007, The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy, Epilepsia, 48, 1245, 10.1111/j.1528-1167.2007.01093.x
Markowitz, 2010, The pharmacokinetic of commonly used antiepileptic drugs in immature CD1 mice, Neuroreport, 21, 452, 10.1097/WNR.0b013e328338ba18
Zapata, 2009, Detection and quantification of neurotransmitters in dialysates, Curr Protoc Neurosci, 7, 1
Spijker, 2011, Dissection of rodent brain regions, 13
Gawande, 2015, Pharmacological validation of in-silico guided novel nootropic potential of Achyranthes aspera L, J Ethnopharmacol, 175, 324, 10.1016/j.jep.2015.09.025
Junyent, 2009, Prevention of epilepsy by taurine treatments in mice experimental model, J Neurosci Res, 87, 1500, 10.1002/jnr.21950
Li, 2000, The effect of pentylenetetrazole kindling on extracellular glutamate and taurine levels in the frontal cortex of rats, Neurosci, 282, 117
Rogawski, 2013, The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs, Epilepsia, 54, 33, 10.1111/epi.12182
